243 related articles for article (PubMed ID: 23417926)
1. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis.
Maskrey BH; Megson IL; Rossi AG; Whitfield PD
Mol Nutr Food Res; 2013 Aug; 57(8):1390-400. PubMed ID: 23417926
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
3. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
Kwon Y
Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
[TBL] [Abstract][Full Text] [Related]
4. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
5. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
Simopoulos AP; Serhan CN; Bazinet RP
Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids and inflammatory processes.
Calder PC
Nutrients; 2010 Mar; 2(3):355-374. PubMed ID: 22254027
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
Seki H; Tani Y; Arita M
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):126-30. PubMed ID: 19737659
[TBL] [Abstract][Full Text] [Related]
8. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ
J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
[TBL] [Abstract][Full Text] [Related]
9. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids.
Zhang MJ; Spite M
Annu Rev Nutr; 2012 Aug; 32():203-27. PubMed ID: 22404117
[TBL] [Abstract][Full Text] [Related]
10. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
11. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
[TBL] [Abstract][Full Text] [Related]
13. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
14. Resolvins and protectins: mediating solutions to inflammation.
Kohli P; Levy BD
Br J Pharmacol; 2009 Oct; 158(4):960-71. PubMed ID: 19594757
[TBL] [Abstract][Full Text] [Related]
15. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Serhan CN; Gotlinger K; Hong S; Arita M
Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.
Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the dietary omega-3 fatty acids impact on murine psoriasis-like skin inflammation and associated lipid dysfunction.
Sorokin AV; Arnardottir H; Svirydava M; Ng Q; Baumer Y; Berg A; Pantoja CJ; Florida EM; Teague HL; Yang ZH; Dagur PK; Powell-Wiley TM; Yu ZX; Playford MP; Remaley AT; Mehta NN
J Nutr Biochem; 2023 Jul; 117():109348. PubMed ID: 37044136
[TBL] [Abstract][Full Text] [Related]
18. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.
Serhan CN
J Thromb Haemost; 2009 Jul; 7 Suppl 1():44-8. PubMed ID: 19630766
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases.
Giudetti AM; Cagnazzo R
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):57-67. PubMed ID: 23064030
[TBL] [Abstract][Full Text] [Related]
20. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
Calder PC
Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]